Literature DB >> 6286063

Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man.

V LoCascio, S Adami, L V Avioli, L Cominacini, G Galvanini, C Gennari, B Imbimbo, L A Scuro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6286063     DOI： 10.1007/bf02411257

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  7 in total

1.  Plasma calcitonin in normal man. Differences between men and women.

Authors:  H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Effect of cortisone treatment on the active transport of calcium by the small intestine.

Authors:  D V Kimberg; R D Baerg; E Gershon; R T Graudusius
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

3.  Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro.

Authors:  W A Peck; J Brandt; I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

4.  Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1,25-dihydroxyvitamin D3.

Authors:  J J Feher; R H Wasserman
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

5.  The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3.

Authors:  M Carré; O Ayigbedé; L Miravet; H Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

6.  Age-related changes of calcitonin secretion in females.

Authors:  I M Shamonki; A M Frumar; I V Tataryn; D R Meldrum; B H Davidson; J G Parthemore; H L Judd; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

7.  Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.

Authors:  R W Chesney; R B Mazess; A J Hamstra; H F DeLuca; S O'Reagan
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321
  7 in total
  7 in total

Review 1.  Glucocorticoid-induced osteoporosis.

Authors:  J D Ringe
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

2.  Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.

Authors:  L Montemurro; G Schiraldi; P Fraioli; G Tosi; A Riboldi; G Rizzato
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

3.  Corticosteroids and bone.

Authors:  W Peck; C Gennari; L Raisz; P Meunier; E Ritz; S Krane; G Nuki; L V Avioli
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

4.  Salmon calcitonin in the therapy of corticoid-induced osteoporosis.

Authors:  J D Ringe; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.

Authors:  J H Healey; S A Paget; P Williams-Russo; T P Szatrowski; R Schneider; H Spiera; H Mitnick; K Ales; P Schwartzberg
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

6.  Serum levels of calcitonin in Cushing's syndrome.

Authors:  G Luisetto; F Mantero; M Boscaro; L Tizian; M Zangari; D Ziliotto
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

7.  The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.

Authors:  A T Hattersley; K Meeran; J Burrin; P Hill; R Shiner; H K Ibbertson
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.